Currently out of the existing stock ratings of Brian Wright, 26 are a BUY (86.67%), 4 are a HOLD (13.33%).

Brian Wright

Work Performance Price Targets & Ratings Chart

Analyst Brian Wright, carries an average stock price target met ratio of 66.36% that have a potential upside of 31.02% achieved within 304 days.

Brian Wright’s has documented 58 price targets and ratings displayed on 13 stocks. The coverage was on Basic Materials, Industrials, Consumer Defensive, Healthcare sectors.

Most recent stock forecast was given on BIOX, Bioceres Crop Solutions Corp at 09-Feb-2024.

Wall Street Analyst Brian Wright

Analyst best performing recommendations are on XXII (22ND CENTURY GROUP).
The best stock recommendation documented was for XXII (22ND CENTURY GROUP) at 8/23/2023. The price target of $248400 was fulfilled within 85 days with a profit of $751600 (75.16%) receiving and performance score of 8.84.

Average potential price target upside

of $15.7 (33.1%) on CTVA (CORTEVA).
of $13.94 (29.16%) on ANDE (THE ANDERSONS).
of $11.87 (9.44%) on LNN (LINDSAY).

CTVA Corteva LNN Lindsay EVGN Evogene LOCL Local Bounti Corp ANDE The Andersons BIOX Bioceres Crop Solutions Corp PAHC Phibro Animal Health XXII 22nd Century Group ADM Archer-Daniels-Midland Company BG Bunge MOH Molina Healthcare WCG WellCare Health Plans UGRO Urban-Gro

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

John Roberts (MIZUHO)